Author name: TB Alliance

Bay Area biotech leaders are in the forefront of a movement to teach our profit-driven drug development industry how to

Two stakeholders of the TB Alliance are partnering to establish a South African Clinical Trials Consortium with an emphasis on

The TB Alliance Stakeholders Meeting was held in conjunction with the annual International Union Against Tuberculosis and Lung Disease (IUATLD)

The TB Alliance Scientific Advisory Committee (SAC) reviewed progress and outlined future research directions for the ongoing R&D strategy of

The International Union Against Tuberculosis and Lung Disease (IUATLD), one of the TB Alliance Stakeholders, hosted its annual World Conference

The Global Alliance for TB Drug Development (TB Alliance) is holding its Stakeholders Association Meeting on October 7, 2002 in

The Commission on Intellectual Property Rights, published its final report: “Integrating Intellectual Property Rights and Development Policy.” The report recommends